CHOLINERGIC MECHANISMS IN ALZHEIMERS-DISEASE

被引:0
|
作者
DAVIES, P [1 ]
机构
[1] UNIV EDINBURGH,MRC,DEPT PHARMACOL,METAB UNIT,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:318 / 319
页数:2
相关论文
共 50 条
  • [21] APPROACHES TO CHOLINERGIC THERAPY IN ALZHEIMERS-DISEASE
    IVERSEN, LL
    PROGRESS IN BRAIN RESEARCH, 1993, 98 : 423 - 426
  • [22] CHOLINERGIC SUPERSENSITIVITY OF THE IRIS IN ALZHEIMERS-DISEASE
    IDIAQUEZ, J
    ALVAREZ, G
    VILLAGRA, R
    SANMARTIN, RA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (12): : 1544 - 1545
  • [23] MORPHOMETRY OF CHOLINERGIC NEURONS IN ALZHEIMERS-DISEASE
    YOUNKIN, SG
    GOODRIDGE, B
    LOCKETT, G
    USIAK, M
    YOUNKIN, LH
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1986, 45 (03): : 341 - 341
  • [24] ANTIBODIES TO CHOLINERGIC NEURONS IN ALZHEIMERS-DISEASE
    CHAPMAN, J
    BACHAR, O
    KORCZYN, AD
    WERTMAN, E
    MICHAELSON, DM
    JOURNAL OF NEUROCHEMISTRY, 1988, 51 (02) : 479 - 485
  • [25] BRITISH-PHARMACOLOGICAL-SOCIETY SYMPOSIUM - ALZHEIMERS-DISEASE - CENTRAL CHOLINERGIC MECHANISMS
    CAULFIELD, M
    SMITH, C
    NEUROBIOLOGY OF AGING, 1985, 6 (01) : 61 - 63
  • [26] BRAIN MECHANISMS IN ALZHEIMERS-DISEASE
    COYLE, JT
    PRICE, DL
    DELONG, MR
    HOSPITAL PRACTICE, 1982, 17 (11): : 55 - 63
  • [27] NONCHOLINERGIC MECHANISMS IN ALZHEIMERS-DISEASE
    IACONO, RP
    SANDYK, R
    ANNALS OF NEUROLOGY, 1987, 21 (03) : 311 - 312
  • [28] INFLAMMATORY MECHANISMS IN ALZHEIMERS-DISEASE
    EIKELENBOOM, P
    ZHAN, SS
    VANGOOL, WA
    ALLSOP, D
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (12) : 447 - 450
  • [29] ALTERATIONS IN CHOLINERGIC NEURONS AND CHOLINERGIC NEUROTRANSMITTER RECEPTORS IN ALZHEIMERS-DISEASE
    WHITEHOUSE, PJ
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1986, 31 (1-4) : 221 - 221
  • [30] CHOLINERGIC THERAPIES FOR ALZHEIMERS-DISEASE - PALLIATIVE OR DISEASE ALTERING
    DAVIS, RE
    DOYLE, PD
    CARROLL, RT
    EMMERLING, MR
    JAEN, J
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (3A): : 425 - 431